Brevel and The Wave Group have announced a joint venture to construct a pioneering illuminated fermentation facility in Uttar Pradesh, India, with an investment ranging from $10 million to $15 million. As US-based companies explore global partnerships, this strategic move underscores the growing significance of biomanufacturing innovations in the food and nutraceutical markets.
What Happened
Brevel, an Israeli climate biotechnology company, and The Wave Group, an Indian conglomerate, have formed a 50/50 joint venture to build a large-scale illuminated fermentation biomanufacturing plant. The facility will be located in Uttar Pradesh and is expected to start construction in late 2026, with operations commencing approximately 18 months later. This project will significantly expand Brevel's production capacity from its current 5,000-liter bioreactor in Israel to a massive 300,000 liters. The plant will initially produce Purallis, Brevel's clean-label chlorella product, while also serving as a platform for other microalgae and plant-cell culture ingredients. Brevel's technology, protected by four patents, integrates conventional fermentation with controlled light exposure, enabling the production of chlorophyll and carotenoids through photosynthetic microorganisms. By leveraging side streams from The Wave Group's sugar mills, the venture aims to create a circular economy model, reducing transportation costs and emissions.
What This Means for Your Business
This joint venture presents significant opportunities for US companies involved in biomanufacturing and sustainable production processes. The facility's increased capacity and innovative technology could open doors for partnerships with firms looking to incorporate sustainable and scalable fermentation solutions into their operations. The collaboration with The Wave Group offers Brevel enhanced infrastructure access, providing a competitive edge in the global food, nutraceutical, and pharmaceutical markets. For companies in the US, this development could mean new procurement opportunities and access to cutting-edge technology in illuminated fermentation, potentially lowering costs and increasing ROI.
What US Operators Should Watch
US operators should closely monitor the development timelines of this project, particularly the commencement of construction in 2026 and the anticipated production start 18 months later. This timeline could align with strategic planning for integrating biomanufacturing processes or forming partnerships with Brevel and The Wave Group. Additionally, keeping an eye on regulatory compliance and potential procurement windows related to biomanufacturing innovations will be crucial for staying competitive in this evolving market.
Source: https://pulse2.com/brevel-and-wave-group-form-10-million-to-15-million-jv-for-illuminated-fermentation-plant-in-india/. Read the original story ->
Is your firm ready for what’s next?
VisioneerIT helps AECM and government contractors modernize operations, achieve compliance, and implement AI.
Explore VisioneerIT Solutions →
